Jerry Zak

Assistant Professor at Huntsman Cancer Institute, University of Utah

[Jerry Zak @zakjerry1]

Thank you to my co-author and myeloid expert Dr Judy Varner @UCSDHealth and the editors at @jitcancer for publishing our work. @huntsmancancer @UofUHealth (9/9)

[Jerry Zak @zakjerry1]

Today I'm excited to present our new review article on myeloid cells in cancer immunotherapy in JITC. Myeloid infiltration in cancer is typically associated with worse prognosis, but is that always the case? (1/n)
https://t.co/t05u81lIOe

[Jerry Zak @zakjerry1]

...microbiome, hypoxia, functional state of non-malignant cells in the tumor microenvironment. A major goal of cancer immunotherapy is finding modifiable factors that maximize the chance of net immune-enhancing myeloid immunity, likely requiring combination therapies. (8/n)

[Jerry Zak @zakjerry1]

@JannatulChaity7 There are application and contact details in the links I shared above

[Jerry Zak @zakjerry1]

Job opportunity in cancer immunology: my lab at the Huntsman Cancer Institute, U. of Utah is hiring a lab technician to join our research program on cancer immunotherapy. Links to job post and lab info available in below. (1/2)

[Jerry Zak @zakjerry1]

@huntsmancancer @uofu

[Jerry Zak @zakjerry1]

This posting is for a junior position, but more senior candidates are welcome to apply and/or contact me for more details. Happy to answer questions!
https://t.co/nccGRjb6Oq
https://t.co/yGSi1UhJUB

[Jerry Zak @zakjerry1]

Check out the paper for more details - open access at PLoS Comput. Biol.! Thanks to my co-first author Ian Newman, other CBB co-leaders Sabah, Daniel and Haissi, all co-authors, all CBB members and PCB editors! (12/12)
https://t.co/bn9caVf64C

[Jerry Zak @zakjerry1]

Excited to introduce our new paper just out in PLoS Computational Biology. In this study, we tackled a common problem: the progress in computational research outpaces the ability of scientists to learn about and implement new methods. (1/12)
https://t.co/bn9caVf64C

[Jerry Zak @zakjerry1]

Notably, this model can be scaled to an inter-institutional network with the video-conference platform and indeed scientists from other San Diego institutions joined our events (UCSD, SIO, Salk, SBP, local biotechs). (11/12)